We provide support from basic and clinical research to treatment!
Genetic Lab Co., Ltd. utilizes its core technology of pathological diagnostic techniques and cutting-edge molecular biology-related technologies to promote the exploration and evaluation of biomarkers, diagnostic methods, and the development of diagnostic drugs. Additionally, we have launched a new service that merges our two business areas, offering a "biomarker exploration and evaluation service" using organizational pathological methods and advanced analytical technologies. We aim to establish this new service as the third pillar of our business and respond to the development of diversified treatments and diagnostics, including personalized medicine, which is expected to grow in the future. [Features] - Contributing to regional healthcare through pathological diagnosis - Actively supporting research and development in dramatically evolving cutting-edge fields - Promoting personalized medicine that will lead the next generation *For more details, please refer to our catalog or feel free to contact us.
Inquire About This Product
basic information
**Our Strengths** ■Pathological Analysis Technology In the Pathology Division, we process biopsy and surgical materials, liquid cytology specimens, etc., to create accurate samples and conduct pathological diagnoses by full-time pathologists. ■Advanced Medical Technology In the Advanced Medical Division, we support numerous researchers and companies aiming to explore biomarkers, identify involved molecules, or guide treatment strategies and prognosis assessments for difficult diseases by analyzing minute molecular-level changes and fluctuations in genes and proteins associated with diseases. ■Innovation through the Fusion of Pathological Analysis Technology and Advanced Medical Technology In the Clinical Trials Division, we evaluate biomarkers through protein and gene analysis of tissue samples under the supervision of full-time pathologists, perform selective tissue sampling using laser microdissection, and create cell and tissue arrays. *For more details, please download the catalog or contact us.*
Price range
Delivery Time
Applications/Examples of results
For more details, please download the catalog or contact us.
Company information
Eurofins Genetic Lab Co., Ltd. utilizes its core technology of pathological diagnostic techniques and cutting-edge molecular biology-related technologies to promote the exploration and evaluation of biomarkers, diagnostic methods, and the development of diagnostic drugs. Established in September 2000 as the first national university-originated industry-academia collaboration venture company, we have been conducting measurements of genes and proteins using state-of-the-art equipment. To date, we have provided services primarily to many universities, university hospitals, and public research institutions.
![[Research Material] Global Market for Organization-Based Diagnostics](https://image.mono.ipros.com/public/product/image/0fc/2001467078/IPROS75017388993807023887.jpeg?w=280&h=280)
![[Market Report] Global Infectious Disease Diagnostics Market](https://image.mono.ipros.com/public/product/image/4d7/2001114376/IPROS25738541128145660180.jpeg?w=280&h=280)
![[Market Report] North American Nuclear Medicine Market](https://image.mono.ipros.com/public/product/image/682/2000979083/IPROS80039324724905149330.jpeg?w=280&h=280)
![[Research Material] Global Market for Neurological Diagnostic Equipment](https://image.mono.ipros.com/public/product/image/408/2001467350/IPROS75157358878367610432.jpeg?w=280&h=280)
